Lundoch Diagnostics
Lundoch Diagnostics is developing an AI-based diagnostic tool using follistatin as a biomarker for type 2 diabetes. By imputing patented blood biomarker measurements, the program predicts type 2 diabetes many years before diabetes onset. Type 2 diabetes is a growing global epidemic, with 6% of the world population suffering from the disease. Early detection of type 2 diabetes risk before symptoms
https://www.innovation.lu.se/en/lu-holding/portfolio-companies/lundoch-diagnostics - 2026-05-29
